Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

3-amino-1-phenylbutane

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Whole Escherichia coli cells overexpressing ω‐transaminase (ω‐TA) and immobilized cells entrapped in LentiKats® were used as… Expand
Is this relevant?
2001
2001
The purpose of this study was to obtain information on the photochemical and phototoxic properties of Labetalol, a beta-blocker… Expand
Is this relevant?
2001
2001
Screening methods based on liquid chromatography (HPLC) and capillary electrophoresis (CE) have been developed for the… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table I
Is this relevant?
1995
1995
A metabolite of labetalol that is responsible for previous reports of false-positive assays for amphetamines by thin-layer… Expand
Is this relevant?
1993
1993
Labetalol causes significant maternal and fetal metabolic effects in pregnant sheep (Yeleswaram et al., J. Pharmacol. Exp. Ther… Expand
Is this relevant?
1991
1991
We previously identified 3-amino-1-phenylbutane (APB) as an oxidative N-dealkylated, metabolite of the antihypertensive agent… Expand
Is this relevant?
1988
1988
Previous studies on the metabolic fate of antihypertensive agent labetalol in humans identified only conjugated metabolites of… Expand
Is this relevant?